Methyl 2-[[4-(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]carbamoylsulfamoyl]-3-methylbenzoate

Methyl 2-[[4-(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]carbamoylsulfamoyl]-3-methylbenzoate is a complex organic compound with the molecular formula C17H19F3N6O6S and CAS number 126535-15-7. This triazine derivative has a molecular weight of 492.4 g/mol and contains multiple functional groups including dimethylamino, trifluoroethoxy, carbamoylsulfamoyl, and methylbenzoate moieties. It is classified as a suspected carcinogen (Category 2) and poses acute and chronic aquatic toxicity risks.

This compound is a solid organic substance with a molecular weight of 492.4 g/mol and contains fluorine atoms which typically influence its physicochemical behavior. The presence of multiple polar functional groups (carbamoylsulfamoyl, ester) and non-polar aromatic rings suggests moderate polarity. The trifluoroethoxy group enhances chemical stability and may affect solubility characteristics. Specific data on melting point, boiling point, density, and solubility parameters should be obtained from detailed technical specifications or safety data sheets.

This compound is primarily used as an intermediate in pharmaceutical and agrochemical synthesis due to its triazine core structure. The complex molecular architecture with carbamoylsulfamoyl linkage suggests applications in developing sulfonylurea-type compounds or related bioactive molecules. Its specific functional groups make it valuable for research and development in medicinal chemistry, particularly for creating compounds with herbicidal or pharmaceutical properties. Industrial applications are typically limited to specialized chemical manufacturing processes.

Safe handling requires appropriate personal protective equipment including chemical-resistant gloves, safety goggles, and protective clothing due to its suspected carcinogenic properties (Category 2). Work should be conducted in well-ventilated areas or under fume hoods to prevent inhalation exposure. Avoid skin contact and ingestion. Use proper laboratory techniques, ensure adequate ventilation, and wash hands thoroughly after handling. Emergency eyewash and safety shower facilities should be readily accessible in work areas.

Store this compound in a cool, dry, well-ventilated area away from heat sources, direct sunlight, and incompatible materials. Keep containers tightly sealed to prevent moisture absorption and contamination. Due to its suspected carcinogenic properties, storage should be in designated areas with restricted access and appropriate labeling. Avoid storage near oxidizing agents, strong acids, or bases. Maintain storage temperature according to manufacturer specifications and ensure proper inventory management with first-in-first-out rotation.

Immediate decontamination is essential due to the compound's hazardous properties. For skin contact, remove contaminated clothing and wash affected area thoroughly with soap and water for at least 15 minutes. In case of eye contact, flush immediately with clean water for 15-20 minutes and remove contact lenses if present. If inhaled, move to fresh air immediately. For ingestion, do not induce vomiting and seek immediate medical attention. Always consult a poison control center or physician after any exposure.

Disposal must comply with local, national, and international environmental regulations due to its aquatic toxicity classification. This compound requires treatment as hazardous waste and should not be discharged to sewers, waterways, or soil. Contact licensed hazardous waste disposal contractors for proper treatment, which may include high-temperature incineration or other approved destruction methods. Maintain detailed waste disposal records and ensure proper waste classification codes are used. Empty containers may also require special handling as hazardous waste.

This compound is classified under ADR Class 9 (Miscellaneous Dangerous Substances), Packing Group III, indicating moderate transport hazard. Packaging must comply with UN specifications and proper dangerous goods documentation is required. Vehicles must carry appropriate emergency response information and drivers need dangerous goods training certification. Packages require proper hazard labels (GHS08, GHS09) and orientation arrows if applicable. Transport should avoid extreme temperatures and ensure secure packaging to prevent spillage during transit.

This compound is subject to multiple regulatory frameworks including REACH registration requirements for European markets and CLP classification obligations. It must be classified with Warning signal word and appropriate GHS pictograms (GHS08, GHS09). As a suspected carcinogen (Category 2) and aquatic toxin, it requires special handling procedures and workplace exposure monitoring. While not currently listed as SVHC, regulatory status may change. Import/export may require permits and safety data sheets must accompany all shipments according to regulatory requirements.

OYSI serves as a reliable European distributor for this specialized chemical compound, offering compliant supply with proper documentation and safety data sheets. As an established chemical distributor, OYSI ensures regulatory compliance with REACH requirements and provides technical support for handling and application questions. Their European distribution network enables efficient logistics while maintaining product integrity and proper hazard communication throughout the supply chain. Contact OYSI directly for availability, specifications, and regulatory documentation requirements.